Indivior Pharmaceuticals Inc (INDV) Stock

Indivior Pharmaceuticals Inc (INDV) is a Healthcare stock trading at $38.31 (as of 2026-06-18), with a market capitalization of $4.39B and a trailing P/E of 18.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Indivior Pharmaceuticals Inc is a holding company that develops, manufactures, and sells buprenorphine-based prescription medicines for treating opioid dependence, including Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates across geographic segments such as the United States, Rest of World, and the United Kingdom.

Valuation — source: SEC EDGAR (first-party)
Price$38.31
Market Cap$4.39B
P/E Ratio18.5
EV / EBITDA13.8
Price / Book-30.50
Price / Sales3.40
DCF Value (model)$-13.65
DCF Upside vs Price-135.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.24B
Net Margin16.9%
Return on Equity-175.0%
Debt / Equity-3.38
Current Ratio0.86
Revenue Growth (YoY)4.3%
EPS Growth (YoY)8300.0%
FCF Growth (YoY)-1428.6%
Financial Health — source: SEC EDGAR
Altman Z-Score3.42 (safe)
Piotroski F-Score3/9 (weak)
Valuation vs Sector & Industry
Stock P/E18.5
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-11.9%
vs Industry7.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($565.17M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJoseph J. Ciaffoni
Employees1,030
CountryUS
IPO Date2014-12-29

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Immunovant, Inc. (IMVT)
  • CRISPR Therapeutics AG (CRSP)
  • Scholar Rock Holding Corporation (SRRK)
  • Arrowhead Pharmaceuticals, Inc. (ARWR)
  • Alkermes plc (ALKS)
  • ACADIA Pharmaceuticals Inc. (ACAD)
  • Crinetics Pharmaceuticals, Inc. (CRNX)
  • ADMA Biologics, Inc. (ADMA)
INDV earnings history · INDV institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.